Therefore, it appears that either the stimulation (PC) or the depletion (HCC) of AR can activate mTORC1; similarly, mTOR inhibition can either stimulate (PC) or repress (HCC) transcriptional activity of the AR. This evidence concerns the gene AR and hepatocellular carcinoma.